Stay updated on Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a new revision label v3.5.4 and removed the previous v3.5.3. This updates the page's version reference to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-05-15T11:56:55.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release/build change without altering the study details shown.
    Difference
    0.1%
    Check dated 2026-04-24T05:58:05.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:29:35.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3. This update seems to be a site versioning change rather than a modification to study content.
    Difference
    0.1%
    Check dated 2026-03-19T04:41:14.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:47:32.000Z thumbnail image
  9. Check
    107 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse operating-status notice and the previous Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T12:11:27.000Z thumbnail image

Stay in the know with updates to Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Nivolumab & PD-L1/IDO Vaccine in Melanoma Clinical Trial page.